Andrew Paterson

Andrew Paterson is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as Chief Marketing Officer and President & Head of Global Innovative Medicine Franchises at EMD Serono, Inc. since May 2018. Previous roles include Senior Vice President Global Business Franchise Neurology & Immunology at EMD Serono, Vice President Global Brand Lead at Merck Group, and Franchise Head for Cardio Metabolic at Novartis. Andrew's tenure at Merck Serono includes leadership roles in Neurology, Endocrinology, and Fertility, demonstrating a strong track record in strategic marketing and P&L management. Academic credentials include an MBA from Hult Ashridge Executive Education and a BSc in Zoology/Animal Biology from The University of Edinburgh.